Posts

Showing posts with the label Intrathecal Drug Delivery System market

COVID-19 Impact Review: What to Expect from Ultrasonic Displacement Sensor Industry in 2020?

-
According to a recent report published by Research Dive, titled, "Ultrasonic Displacement Sensor Market by Type, Component, Transducer Type, and End-users: Global Opportunity Analysis and Industry Forecast, 2019-2025," the global Ultrasonic Displacement Sensor market size was valued at $ 2,627.65 Million in 2018, and is projected to reach $ 4,736.67 Million by 2025, registering a CAGR of 8.86% from 2019 to 2025. North America dominates the market, followed by Europe, Asia-Pacific, and LAMEA. U.S. dominated the global Ultrasonic Displacement Sensor market share in 2018, whereas Canada is expected to grow at a significant rate in the U.S. during the forecast period. Ultrasonic displacement sensors are basically used to detect objects and measure distance in industrial applications in which versatility and reliability are the key factors. For instance, Pepperl+Fuchs offers a wide variety of ultrasonic sensors which feature benefits such as large measuring ranges of up ...
2 comments
Read more

Industry Analysis: How COVID-19 Crisis Impacts on Intrathecal Drug Delivery System Market in Coming Future

-
Since ages, anesthetists have been using the intrathecal (IT) space to provide optimum anesthesia and analgesia. Especially, to help patients bear the pain during the operative period, and also for postoperative pain relief. Cancer pain can arise due to a tumor compressing or infiltrating tissue. In addition to this, pain occurs in 67% of the patients with metastatic cancer. Treatments such as chemotherapy, radiations, and surgery might give rise to painful conditions that continue for a longer duration, even after the treatment is completed. Hence, the method using intrathecal drug delivery system is been considered more beneficial and efficient as compared to the other methods. According to a study of Research Dive, intrathecal drug delivery system market forecast shall surpass $1662 Million by 2027, registering a CAGR of 7.2% from 2019 to 2027. Intrathecal drugs delivery (IDD) system plays the important role in the treatments of intractable (uncontrollable) pain. IDD syste...
Post a Comment
Read more

COVID-19 Impact Review: What to Expect from Intrathecal Drug Delivery System Industry in 2020?

-
Image
Since ages, anaesthetists have been using the intrathecal (IT) space to provide optimum anaesthesia and analgesia. Especially, to help patients bear the pain during the operative period, and also for postoperative pain relief. Cancer pain can arise due to a tumor compressing or infiltrating tissue. In addition to this, pain occurs in 67% of the patients with metastatic cancer. Treatments such as chemotherapy, radiations, and surgery might give rise to painful conditions that continue for a longer duration, even after the treatment is completed. Hence, the method using intrathecal drug delivery system is been considered more beneficial and efficient as compared to the other methods. Benefits of Intrathecal drug delivery system Intrathecal drug delivery treatment is mainly used to give more comfort and relief from chronic pain so that the patient bears the pain and gets cured easily. Some of these drugs have been able to lessen or even eradicate oral or systemic pain medicati...
Post a Comment
Read more